Genoa Healthcare Chief Executive Officer Joe Douglas provides outlook for 2022
2022 will be another important year for the behavioral health community. The increase in mental illness and substance use disorder, along with the staffing challenges and shift to telehealth that we saw in 2021, will continue to impact the health care industry. Our pharmacy teams are prepared to step up with additional services that meet the changing needs of our partners and consumers.
Genoa Healthcare Chief Executive Officer Joe Douglas takes a look at the opportunities for expanded access to care in 2022 and provides an industry outlook in Chain Drug Review’s 2022 forecast. You can read the full article here or view it in Chain Drug Review’s recent issue.